Simple note on negative ionotropy
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Here is a concise note on negative inotropy drawn from authoritative sources:
Negative Inotropy
Definition
Inotropy (inotropism) is the intrinsic ability of myocardial cells to develop force at a given muscle cell length. Agents or conditions that decrease contractility are said to have negative inotropic effects - they reduce both the rate of tension development and the peak tension generated by the myocardium.
- Costanzo Physiology, p. 151
Cellular Basis of Contractility
To understand negative inotropy, the normal mechanism must be clear:
- During the action potential plateau (phase 2), Ca²⁺ enters via L-type (dihydropyridine) channels - this is the trigger Ca²⁺.
- Trigger Ca²⁺ stimulates Ca²⁺-induced Ca²⁺ release from the sarcoplasmic reticulum (SR) via ryanodine receptors - dramatically amplifying intracellular [Ca²⁺].
- Ca²⁺ binds troponin C, displacing tropomyosin, allowing actin-myosin cross-bridge formation and contraction.
- The magnitude of tension is directly proportional to intracellular [Ca²⁺].
Any mechanism that reduces intracellular Ca²⁺ availability or impairs cross-bridge cycling will decrease contractility - producing negative inotropy.
- Costanzo Physiology, p. 151
Mechanisms of Negative Inotropy
1. Beta-1 Adrenoceptor Blockade (Beta-blockers)
- Normally, sympathetic stimulation activates beta-1 receptors → Gs protein → adenylyl cyclase → cAMP → Protein Kinase A (PKA) → phosphorylation of:
- Sarcolemmal L-type Ca²⁺ channels (increased Ca²⁺ influx)
- Phospholamban (increased SR Ca²⁺ storage and release)
- Beta-blockers block this pathway → reduced cAMP → reduced Ca²⁺ influx and SR Ca²⁺ release → decreased contractility
- Clinical note: in acute heart failure, beta-blockers can worsen decompensation due to this effect - slow, gradual titration is mandatory in systolic dysfunction.
- Costanzo Physiology, p. 152; Current Surgical Therapy
2. Non-dihydropyridine Calcium Channel Blockers
- Verapamil and diltiazem directly block L-type Ca²⁺ channels in the myocardium.
- This reduces trigger Ca²⁺ → less SR Ca²⁺ release → less cross-bridge cycling → decreased contractility.
- Verapamil has greater negative inotropic effects than dihydropyridines (e.g., amlodipine, nifedipine) which act more selectively on vascular smooth muscle.
- Combined use with beta-blockers is generally avoided because both drug classes share negative inotropic and chronotropic effects.
- Lippincott Pharmacology; Goldman-Cecil Medicine
3. Parasympathetic (Vagal) Stimulation
- ACh acts on muscarinic receptors coupled to Gi/Gk proteins → inhibits adenylyl cyclase → decreases cAMP.
- Additionally, ACh increases K⁺ conductance (I-K,ACh) → shortens action potential plateau → reduces Ca²⁺ influx.
- Effect is most pronounced in the atria (ventricles have sparse parasympathetic innervation).
- Costanzo Physiology, p. 152
4. Antiarrhythmics (Class IC/Propafenone)
- Propafenone and its metabolite 5-hydroxypropafenone exhibit negative inotropic properties at higher concentrations.
- Well-tolerated when EF >40%, but problematic in pre-existing LV dysfunction.
- Braunwald's Heart Disease
5. Hyperkalemia, Acidosis, Hypoxia
- All depress myocardial contractility by disrupting ion gradients and metabolic processes that sustain Ca²⁺ cycling.
Summary Table
| Mechanism | Agent/Condition | Site of Action |
|---|---|---|
| Block beta-1 → reduce cAMP | Beta-blockers (metoprolol, carvedilol) | Gs-adenylyl cyclase pathway |
| Block L-type Ca²⁺ channels | Verapamil, diltiazem | Sarcolemmal Ca²⁺ entry |
| Inhibit adenylyl cyclase | Parasympathetic/ACh | Gi/Gk → reduced cAMP |
| Na⁺/Ca²⁺ exchanger dysregulation | Acidosis, hypoxia | Intracellular Ca²⁺ handling |
| Direct myocardial depression | Antiarrhythmics (propafenone) | Multiple |
Clinical Relevance
- Hypertrophic obstructive cardiomyopathy (HOCM): Negative inotropy is therapeutic - beta-blockers and verapamil reduce LVOT obstruction by decreasing contractility and allowing better LV filling. - Harrison's Internal Medicine, 22e
- Aortic dissection: Agents with negative inotropic properties (beta-blockers, CCBs, clonidine) are preferred to reduce shear stress on the aortic wall. - Washington Manual of Medical Therapeutics
- Systolic heart failure: Acute negative inotropy (from new beta-blocker initiation) can precipitate decompensation; agents must be started at low doses and uptitrated slowly.
- Drug overdose: Beta-blocker and CCB overdose cause life-threatening cardiogenic shock via profound negative inotropy and AV blockade.
Now translate in Bengali without changing the medical terms
Negative Inotropy
সংজ্ঞা
Inotropy (inotropism) হলো একটি নির্দিষ্ট muscle cell length-এ myocardial cells-এর force develop করার intrinsic ability। যেসব agent বা condition contractility কমায়, তাদের negative inotropic effects আছে বলা হয় - এরা myocardium-এর tension development-এর হার এবং peak tension উভয়ই কমিয়ে দেয়।
Contractility-র Cellular Basis
Negative inotropy বুঝতে হলে স্বাভাবিক mechanism জানা দরকার:
- Action potential-এর plateau (phase 2)-এর সময় L-type (dihydropyridine) channel-এর মাধ্যমে Ca²⁺ প্রবেশ করে - এটি trigger Ca²⁺।
- Trigger Ca²⁺, ryanodine receptor-এর মাধ্যমে sarcoplasmic reticulum (SR) থেকে Ca²⁺-induced Ca²⁺ release উদ্দীপিত করে - ফলে intracellular [Ca²⁺] অনেক বেড়ে যায়।
- Ca²⁺, troponin C-এর সাথে যুক্ত হয়, tropomyosin-কে সরিয়ে দেয়, এবং actin-myosin cross-bridge formation ও contraction সম্ভব হয়।
- Tension-এর মাত্রা সরাসরি intracellular [Ca²⁺]-এর উপর নির্ভরশীল।
যেকোনো mechanism যা intracellular Ca²⁺ availability কমায় বা cross-bridge cycling ব্যাহত করে, তা contractility কমিয়ে দেয় - অর্থাৎ negative inotropy তৈরি করে।
Negative Inotropy-র Mechanism
১. Beta-1 Adrenoceptor Blockade (Beta-blockers)
- স্বাভাবিক অবস্থায়, sympathetic stimulation beta-1 receptor সক্রিয় করে → Gs protein → adenylyl cyclase → cAMP → Protein Kinase A (PKA) → এর ফলে নিচের গুলোর phosphorylation হয়:
- Sarcolemmal L-type Ca²⁺ channel (Ca²⁺ influx বাড়ে)
- Phospholamban (SR-এ Ca²⁺ storage ও release বাড়ে)
- Beta-blockers এই pathway বন্ধ করে → cAMP কমে → Ca²⁺ influx ও SR Ca²⁺ release কমে → contractility কমে যায়
- Clinical note: acute heart failure-এ beta-blockers decompensation আরও খারাপ করতে পারে - systolic dysfunction-এ ধীরে ধীরে titration বাধ্যতামূলক।
২. Non-dihydropyridine Calcium Channel Blockers
- Verapamil ও diltiazem সরাসরি myocardium-এর L-type Ca²⁺ channel বন্ধ করে।
- এতে trigger Ca²⁺ কমে → SR Ca²⁺ release কমে → cross-bridge cycling কমে → contractility কমে যায়।
- Verapamil-এর negative inotropic effect, dihydropyridine-গুলোর (যেমন amlodipine, nifedipine) চেয়ে বেশি, কারণ এরা মূলত vascular smooth muscle-এ কাজ করে।
- Beta-blockers-এর সাথে একসাথে ব্যবহার সাধারণত এড়িয়ে চলা হয়, কারণ উভয় drug class-এর একই রকম negative inotropic ও chronotropic effect রয়েছে।
৩. Parasympathetic (Vagal) Stimulation
- ACh, Gi/Gk protein-এর সাথে যুক্ত muscarinic receptor-এ কাজ করে → adenylyl cyclase inhibit করে → cAMP কমে।
- এছাড়া ACh, K⁺ conductance (I-K,ACh) বাড়ায় → action potential plateau ছোট হয় → Ca²⁺ influx কমে।
- এই effect সবচেয়ে বেশি atria-তে দেখা যায় (ventricle-এ parasympathetic innervation কম)।
৪. Antiarrhythmics (Class IC / Propafenone)
- Propafenone ও এর metabolite 5-hydroxypropafenone বেশি concentration-এ negative inotropic property দেখায়।
- EF >40% হলে সাধারণত সহনীয়, কিন্তু pre-existing LV dysfunction-এ বিপজ্জনক।
৫. Hyperkalemia, Acidosis, Hypoxia
- এগুলো সবই ion gradient ও Ca²⁺ cycling-কে ব্যাহত করে myocardial contractility কমিয়ে দেয়।
সারসংক্ষেপ সারণি
| Mechanism | Agent/Condition | Site of Action |
|---|---|---|
| Block beta-1 → cAMP কমানো | Beta-blockers (metoprolol, carvedilol) | Gs-adenylyl cyclase pathway |
| L-type Ca²⁺ channel বন্ধ করা | Verapamil, diltiazem | Sarcolemmal Ca²⁺ entry |
| Adenylyl cyclase inhibit করা | Parasympathetic/ACh | Gi/Gk → cAMP কমে |
| Na⁺/Ca²⁺ exchanger dysregulation | Acidosis, hypoxia | Intracellular Ca²⁺ handling |
| Direct myocardial depression | Antiarrhythmics (propafenone) | Multiple |
Clinical Relevance
- Hypertrophic obstructive cardiomyopathy (HOCM): Negative inotropy এখানে উপকারী - beta-blockers ও verapamil, contractility কমিয়ে এবং LV filling উন্নত করে LVOT obstruction কমায়।
- Aortic dissection: Negative inotropic property-সম্পন্ন agent (beta-blockers, CCBs, clonidine) পছন্দের, কারণ এরা aortic wall-এর উপর shear stress কমায়।
- Systolic heart failure: নতুন beta-blocker শুরু করলে তীব্র negative inotropy decompensation ডেকে আনতে পারে; তাই কম dose থেকে শুরু করে ধীরে ধীরে বাড়াতে হয়।
- Drug overdose: Beta-blocker ও CCB overdose, profound negative inotropy ও AV blockade-এর মাধ্যমে জীবন-হুমকিস্বরূপ cardiogenic shock তৈরি করতে পারে।
I want medical terminology explanation for this topic
Here is a breakdown of every medical term used in the negative inotropy note:
Medical Terminology: Negative Inotropy
Core Terms
| Term | Origin | Meaning |
|---|---|---|
| Inotropy | Greek: is/inos (fiber) + tropos (turning/changing) | The force or strength of muscular contraction |
| Negative | Latin: negare (to deny) | Indicating a decrease or reduction |
| Inotropic | Same as inotropy | Relating to the force of contraction |
| Chronotropy | Greek: chronos (time) + tropos | Rate of heartbeat (heart rate) |
| Dromotropy | Greek: dromos (running/conduction) + tropos | Speed of electrical conduction through the heart |
| Contractility | Latin: contrahere (to draw together) | Intrinsic ability of myocardial fibers to shorten and generate force |
| Myocardial | Greek: mys (muscle) + kardia (heart) | Relating to the muscle of the heart |
Cellular & Physiological Terms
| Term | Origin | Meaning |
|---|---|---|
| Action potential | Latin: actio (doing) + potentia (power) | Electrical impulse generated across a cell membrane that triggers muscle contraction |
| Plateau (Phase 2) | French: plateau (flat area) | The flat, sustained portion of the cardiac action potential where Ca²⁺ influx balances K⁺ outflow |
| Sarcolemma | Greek: sarx (flesh) + lemma (sheath) | The cell membrane of a muscle fiber |
| Sarcoplasmic reticulum (SR) | Greek: sarx (flesh) + Latin: reticulum (little net) | Internal Ca²⁺ storage organelle in muscle cells |
| Ryanodine receptor | Named after the plant Ryania speciosa | Ca²⁺ release channel on the sarcoplasmic reticulum |
| Troponin C | Greek: tropos (change) + Latin: tonus (tension) | Ca²⁺-binding protein on the thin filament; when Ca²⁺ binds, contraction is initiated |
| Tropomyosin | Greek: tropos + mys (muscle) | Regulatory protein that normally blocks actin-myosin binding; moved by troponin |
| Actin | Greek: aktis (ray/beam) | Thin filament protein that interacts with myosin to produce contraction |
| Myosin | Greek: mys (muscle) | Thick filament motor protein that generates the force of contraction |
| Cross-bridge | Descriptive | Physical link formed between myosin head and actin during contraction |
| Excitation-contraction coupling | Latin: excitare (to rouse) + contrahere | The process linking electrical excitation of a cell to its mechanical contraction |
| Phospholamban | Greek: phospho (light/phosphorus) + lambanein (to take) | Regulatory protein in SR membrane; when phosphorylated, stimulates Ca²⁺ ATPase |
Receptor & Signaling Terms
| Term | Origin | Meaning |
|---|---|---|
| Beta-1 adrenoceptor | Greek: beta (2nd letter) + Latin: ad (near) + ren (kidney, referring to adrenal gland) | Receptor subtype on myocardial cells that responds to catecholamines (adrenaline, noradrenaline) |
| Muscarinic receptor | Named after muscarine (toxin from mushroom Amanita muscaria) | Receptor that responds to acetylcholine; mediates parasympathetic effects |
| Gs protein | G = guanine nucleotide-binding; s = stimulatory | G-protein that activates adenylyl cyclase |
| Gi/Gk protein | i = inhibitory; k = relating to K⁺ channel | G-protein that inhibits adenylyl cyclase or opens K⁺ channels |
| Adenylyl cyclase | Greek: adeno (gland) + kyklos (circle) | Enzyme that converts ATP to cAMP; key amplifier of beta-adrenergic signaling |
| cAMP | Cyclic adenosine monophosphate | Second messenger produced by adenylyl cyclase; activates Protein Kinase A |
| Protein Kinase A (PKA) | Greek: kinein (to move) | Enzyme activated by cAMP; phosphorylates target proteins to increase Ca²⁺ |
| Phosphorylation | Greek: phosphoros (light-bearing) | Addition of a phosphate group to a protein, changing its activity |
| I-K,ACh | Abbreviation | Acetylcholine-activated inward-rectifier K⁺ current; shortens action potential |
Drug Class Terms
| Term | Origin | Meaning |
|---|---|---|
| Beta-blocker | Descriptive | Drug that blocks beta-adrenergic receptors, reducing heart rate and contractility |
| Calcium channel blocker (CCB) | Descriptive | Drug that blocks voltage-gated Ca²⁺ channels in cardiac or vascular smooth muscle |
| Dihydropyridine | Chemical name | Subclass of CCBs (e.g., amlodipine, nifedipine) acting mainly on vascular smooth muscle; less negative inotropy |
| Non-dihydropyridine | Chemical name | Subclass of CCBs (e.g., verapamil, diltiazem) acting on both heart and vessels; significant negative inotropy |
| Antiarrhythmic | Greek: anti (against) + a (without) + rhythmos (rhythm) | Drug used to treat abnormal heart rhythms |
| Class IC | Vaughan-Williams classification | Antiarrhythmic subclass that strongly blocks Na⁺ channels; includes propafenone, flecainide |
| Catecholamine | Greek: catechol (a chemical ring) + amine | Group of hormones/neurotransmitters (adrenaline, noradrenaline, dopamine) derived from tyrosine |
| ACh (Acetylcholine) | Chemical name | Parasympathetic neurotransmitter released at muscarinic receptors |
Clinical Condition Terms
| Term | Origin | Meaning |
|---|---|---|
| Heart failure | Descriptive | Condition where the heart cannot pump sufficient blood to meet the body's needs |
| Systolic dysfunction | Greek: systole (contraction) + dys (bad) + funktio (performance) | Impaired ability of the ventricle to contract and eject blood; reduced EF |
| Ejection fraction (EF) | Latin: ejectio (throwing out) + fractio (breaking) | Percentage of blood ejected from the ventricle per beat; normal >55% |
| Decompensation | Latin: de (reversal) + compensare (to balance) | Worsening of heart failure when the heart can no longer maintain adequate output |
| HOCM | Abbreviation | Hypertrophic Obstructive Cardiomyopathy - genetic disease with abnormal thickening of heart muscle causing LVOT obstruction |
| Hypertrophic | Greek: hyper (over) + trophe (nourishment) | Abnormal increase in the size/thickness of an organ |
| LVOT | Abbreviation | Left Ventricular Outflow Tract - the channel through which blood exits the left ventricle into the aorta |
| Aortic dissection | Greek: aorte (great artery) + Latin: dissectio (cutting apart) | Tear in the inner layer of the aorta allowing blood to track between layers |
| Cardiogenic shock | Greek: kardia + genein (to produce) + French: choc | Life-threatening circulatory failure caused by severe impairment of cardiac pumping |
| AV block | Abbreviation | Atrioventricular block - impaired conduction between atria and ventricles |
| Titration | French: titre (standard) | Process of gradually adjusting drug dose to achieve the desired effect safely |
Ion & Transport Terms
| Term | Origin | Meaning |
|---|---|---|
| L-type Ca²⁺ channel | L = Long-lasting | Voltage-gated Ca²⁺ channel responsible for trigger Ca²⁺ during the action potential plateau |
| Ca²⁺ ATPase | Chemical abbreviation | Enzyme that uses ATP energy to pump Ca²⁺ back into the SR or out of the cell |
| Na⁺/Ca²⁺ exchanger | Chemical abbreviation | Membrane transporter that uses the Na⁺ gradient to extrude Ca²⁺ from the cell |
| Hyperkalemia | Greek: hyper (excess) + Latin: kalium (potassium) + Greek: haima (blood) | Elevated serum potassium; depresses cardiac contractility |
| Acidosis | Latin: acidus (sour) + osis (condition) | Abnormally low blood pH; impairs Ca²⁺ handling and cross-bridge cycling |
| Hypoxia | Greek: hypo (under) + oxys (sharp/oxygen) | Reduced oxygen supply to tissue; impairs myocardial energy production |
| Shear stress | Physics term | Mechanical force acting tangentially along the aortic wall due to blood flow |
This covers every key term in the note - from root words to clinical usage. Each term is best remembered by breaking it into its Greek or Latin roots, which often reveals the meaning directly.
I want medical terminology explanation for this topic
Asking for Preferences
It looks like the previous response already covered this exactly - root word breakdowns plus plain-English definitions for every term in the Negative Inotropy note. Let me give you a cleaner, more structured version with both roots and definitions organized by system:
Medical Terminology: Negative Inotropy
Root Words + Plain-English Definitions
1. The Core Word: Inotropy
| Word | Roots | Plain Definition |
|---|---|---|
| Inotropy | inos (Gk: fiber/muscle) + tropos (Gk: turning, changing) | The force or strength of a heartbeat contraction |
| Negative inotropy | negare (L: to deny) + above | A reduction in the force of heart muscle contraction |
| Positive inotropy | positivus (L: placed, certain) + above | An increase in the force of heart muscle contraction |
| Inotropic agent | Above + agere (L: to act) | Any drug or substance that changes contraction force |
| Chronotropy | chronos (Gk: time) + tropos | Heart rate - how fast the heart beats |
| Dromotropy | dromos (Gk: running, a course) + tropos | Conduction speed - how fast electrical impulse travels through the heart |
| Lusitropy | lysis (Gk: loosening) + tropos | Relaxation of the heart muscle (diastolic function) |
2. Heart Muscle Anatomy Terms
| Word | Roots | Plain Definition |
|---|---|---|
| Myocardium | mys (Gk: muscle) + kardia (Gk: heart) | The muscular wall of the heart |
| Myocardial | Same | Relating to the heart muscle |
| Sarcolemma | sarx (Gk: flesh/muscle) + lemma (Gk: sheath/husk) | The outer cell membrane of a muscle fiber; controls what enters/exits the cell |
| Sarcoplasm | sarx + plasma (Gk: something formed) | The cytoplasm (inner fluid) of a muscle cell |
| Sarcoplasmic reticulum (SR) | sarx + reticulum (L: little net) | A network of tubes inside the muscle cell that stores and releases Ca²⁺ |
| Sarcomere | sarx + meros (Gk: part) | The basic contractile unit of a muscle fiber |
| Cardiomyocyte | kardia + mys + kytos (Gk: cell) | Individual heart muscle cell |
3. Contraction Machinery Terms
| Word | Roots | Plain Definition |
|---|---|---|
| Actin | aktis (Gk: ray/beam) | The thin filament protein; provides the "track" for myosin to pull along |
| Myosin | mys (Gk: muscle) | The thick filament "motor" protein; its head grabs actin and pulls it |
| Cross-bridge | Descriptive English | The physical link formed when a myosin head attaches to actin to generate force |
| Troponin | tropos (Gk: turning) + tonus (L: tension) | Protein complex on actin that acts as the "on/off switch" for contraction |
| Troponin C | C = calcium-binding subunit | The Ca²⁺-binding part of troponin; when Ca²⁺ attaches here, contraction begins |
| Troponin I | I = inhibitory subunit | Normally inhibits actin-myosin interaction; released when Ca²⁺ binds troponin C |
| Troponin T | T = tropomyosin-binding subunit | Anchors the troponin complex to tropomyosin |
| Tropomyosin | tropos + mys (Gk: muscle) | Protein strand that physically covers actin's binding sites; moved aside when troponin activates |
| Contractility | contrahere (L: to draw together) | The intrinsic ability of the heart muscle to generate force, independent of load |
4. Calcium Handling Terms
| Word | Roots | Plain Definition |
|---|---|---|
| L-type Ca²⁺ channel | L = Long-lasting (pharmacological descriptor) | Voltage-gated channel in the cell membrane that lets Ca²⁺ enter during the action potential plateau |
| Trigger Ca²⁺ | Descriptive | The small amount of Ca²⁺ entering through L-type channels that "triggers" the bigger SR release |
| Ca²⁺-induced Ca²⁺ release (CICR) | Descriptive | Process where a small Ca²⁺ entry causes a much larger Ca²⁺ release from the SR |
| Ryanodine receptor | Named after Ryania speciosa plant (where the toxin ryanodine was isolated) | Ca²⁺ release channel on the SR membrane; opened by trigger Ca²⁺ |
| Phospholamban | phospho (Gk: light/phosphate) + lambanein (Gk: to take/receive) | A regulatory protein in the SR that, when phosphorylated, speeds up Ca²⁺ reuptake |
| Ca²⁺ ATPase | ATP = adenosine triphosphate + -ase (enzyme suffix) | Enzyme that uses ATP energy to pump Ca²⁺ back into the SR (causing relaxation) |
| Na⁺/Ca²⁺ exchanger (NCX) | Chemical symbols | Membrane transporter that removes Ca²⁺ from the cell using the Na⁺ gradient as energy |
5. Electrical/Action Potential Terms
| Word | Roots | Plain Definition |
|---|---|---|
| Action potential | actio (L: doing) + potentia (L: power/ability) | The brief electrical signal that travels across the cell membrane to trigger contraction |
| Plateau (Phase 2) | French: plateau (flat area/high ground) | The sustained flat part of the cardiac action potential where Ca²⁺ flows in to maintain depolarization |
| Depolarization | de- (L: reversal) + polus (L: pole) | The process of the cell membrane becoming less negative inside, triggering an action potential |
| Repolarization | re- (L: again) + polus | Restoration of the resting membrane potential after an action potential |
| Excitation-contraction coupling | excitare (L: to rouse/stir up) + contrahere | The entire process linking an electrical signal to the mechanical act of muscle shortening |
| I-K,ACh current | Abbreviation | Acetylcholine-activated potassium current; opens K⁺ channels to shorten the action potential |
6. Receptor & Signaling Terms
| Word | Roots | Plain Definition |
|---|---|---|
| Receptor | recipere (L: to receive) | A protein on a cell surface or inside the cell that binds a specific molecule (ligand) and triggers a response |
| Beta-1 adrenoceptor (β₁) | beta (Gk: 2nd letter) + ad (L: near) + ren (L: kidney, for adrenal gland) | Receptor on heart muscle that binds adrenaline/noradrenaline to increase rate and force |
| Muscarinic receptor | Named after muscarine (toxin of mushroom Amanita muscaria) | Receptor that binds acetylcholine; mediates parasympathetic (slowing) effects on the heart |
| G-protein | G = guanine nucleotide-binding | A family of signal relay proteins inside the cell that couple receptors to enzymes |
| Gs protein | s = stimulatory | G-protein that stimulates adenylyl cyclase to produce cAMP |
| Gi protein | i = inhibitory | G-protein that inhibits adenylyl cyclase, reducing cAMP production |
| Gk protein | k = relating to K⁺ channel | G-protein that opens potassium channels to reduce Ca²⁺ influx |
| Adenylyl cyclase | adeno (Gk: gland) + kyklos (Gk: circle/ring) | Membrane enzyme that converts ATP into cAMP; key amplifier of the beta-receptor signal |
| cAMP | Cyclic adenosine monophosphate | Second messenger molecule that activates Protein Kinase A |
| Second messenger | Descriptive | An intracellular molecule that relays and amplifies a signal from a surface receptor |
| Protein Kinase A (PKA) | kinein (Gk: to move) + kinase (enzyme that moves phosphate) | Enzyme activated by cAMP; phosphorylates proteins to change their activity |
| Phosphorylation | phosphoros (Gk: light-bearing, from phosphorus) + -ation | Chemical addition of a phosphate (PO₄) group to a protein, activating or deactivating it |
| Catecholamine | catechol (chemical ring structure) + amine (nitrogen-containing compound) | Group of hormones/neurotransmitters (adrenaline, noradrenaline, dopamine) that act on adrenoceptors |
| ACh (Acetylcholine) | acetyl (chemical group) + choline (a B-vitamin derivative) | Main parasympathetic neurotransmitter; slows heart rate and reduces atrial contractility |
7. Drug Class Terms
| Word | Roots | Plain Definition |
|---|---|---|
| Beta-blocker | Descriptive | Drug that blocks beta-adrenoceptors; reduces heart rate, conduction speed, and contractility |
| Calcium channel blocker (CCB) | Descriptive | Drug that blocks voltage-gated Ca²⁺ channels; reduces Ca²⁺ entry into cells |
| Dihydropyridine | di- (L: two) + hydro (Gk: water) + pyridine (chemical ring) | CCB subclass (amlodipine, nifedipine) that acts mainly on blood vessels; minimal cardiac inotropy |
| Non-dihydropyridine | non- (L: not) + above | CCB subclass (verapamil, diltiazem) that acts on both heart and vessels; significant negative inotropy |
| Antiarrhythmic | anti- (Gk: against) + a- (Gk: without) + rhythmos (Gk: rhythm) | Drug that corrects abnormal heart rhythms |
| Class IC | Vaughan-Williams pharmacological classification | Antiarrhythmic subclass with strong Na⁺ channel blocking; e.g., propafenone, flecainide |
| Propafenone | Chemical/proprietary name | Class IC antiarrhythmic with additional beta-blocking and mild Ca²⁺ channel blocking properties; negative inotropic at high doses |
8. Clinical Condition Terms
| Word | Roots | Plain Definition |
|---|---|---|
| Heart failure | Descriptive English | The heart cannot pump enough blood to meet the body's demands |
| Systolic | systole (Gk: contraction, drawing together) | Relating to the contraction phase of the cardiac cycle |
| Diastolic | diastole (Gk: expansion, drawing apart) | Relating to the relaxation/filling phase of the cardiac cycle |
| Systolic dysfunction | systole + dys- (Gk: bad/impaired) + functio (L: performance) | Inability of the ventricle to contract forcefully enough; reduced ejection fraction |
| Ejection fraction (EF) | ejectio (L: throwing out) + fractio (L: a breaking/portion) | The percentage of blood pumped out of the ventricle with each beat; normal >55% |
| Decompensation | de- (L: undoing) + compensare (L: to weigh together, balance) | When the heart can no longer maintain adequate output despite compensatory mechanisms |
| Titration | titulus (L: inscription/standard) via French titre | Gradually adjusting a drug dose upward to find the smallest effective dose with fewest side effects |
| HOCM | Acronym | Hypertrophic Obstructive Cardiomyopathy - genetic thickening of heart muscle obstructing blood outflow |
| Hypertrophic | hyper- (Gk: above/excess) + trophe (Gk: nourishment) | Abnormal increase in the size or bulk of an organ or tissue |
| Cardiomyopathy | kardia + mys + pathos (Gk: disease/suffering) | Disease of the heart muscle itself |
| LVOT | Acronym | Left Ventricular Outflow Tract - the passage from the left ventricle into the aorta |
| Obstruction | obstruere (L: to build against, block) | Partial or complete blockage of a passage or channel |
| Aortic dissection | aorte (Gk: great vessel) + dissectio (L: cutting apart) | A tear in the inner wall of the aorta where blood splits the layers apart |
| Cardiogenic shock | kardia + genein (Gk: to produce/originate) + choc (French: violent impact) | Life-threatening collapse of circulation caused by severe pump failure of the heart |
| AV block | atrium (L: entrance hall) + ventriculus (L: little belly) | Impaired electrical conduction between the upper and lower chambers of the heart |
| Hyperkalemia | hyper- + kalium (L/Arabic: potassium) + haima (Gk: blood) | Abnormally high potassium level in the blood; depresses myocardial excitability |
| Acidosis | acidus (L: sour) + -osis (Gk: condition/process) | A state of excess acid in the blood (pH <7.35); impairs Ca²⁺ cycling and contractility |
| Hypoxia | hypo- (Gk: under/below) + oxys (Gk: sharp/oxygen) | Insufficient oxygen delivery to tissues; impairs ATP production needed for contraction |
Quick Root Reference Card
| Root | Language | Meaning | Example |
|---|---|---|---|
| mys/myo- | Greek | Muscle | Myocardium, myosin |
| kardia/cardio- | Greek | Heart | Cardiomyopathy, cardiology |
| sarco- | Greek | Flesh/muscle | Sarcolemma, sarcomere |
| tropos | Greek | Turning/change | Inotropy, chronotropy |
| inos | Greek | Fiber | Inotropy |
| chronos | Greek | Time | Chronotropy |
| hyper- | Greek | Excess/above | Hyperkalemia, hypertrophic |
| hypo- | Greek | Below/under | Hypoxia, hypotension |
| anti- | Greek | Against | Antiarrhythmic |
| de- | Latin | Reversal/away | Depolarization, decompensation |
| -ase | Enzyme suffix | An enzyme | ATPase, kinase |
| -osis | Greek | Condition/process | Acidosis, fibrosis |
| -pathy | Greek: pathos | Disease | Cardiomyopathy |
| kinein | Greek | To move | Kinase, dyskinesia |
| phosphoros | Greek | Light-bearing | Phosphorylation, phospholamban |
This gives you the full breakdown - every term decoded from its roots with a plain working definition beside it. The root card at the bottom is useful for decoding unfamiliar terms you encounter in the future.
This is a shared conversation. Sign in to Orris to start your own chat.